Prescription Medication for Constipation
Start with polyethylene glycol (PEG) 17 g once daily as your first-line prescription for chronic constipation—it is the gold standard based on superior efficacy, safety, cost-effectiveness, and proven long-term durability. 1
First-Line Prescription: Polyethylene Glycol (PEG)
PEG 17 g daily is the definitive first-line choice recommended by the American Gastroenterological Association for chronic idiopathic constipation. 1 This osmotic laxative works by drawing water into the intestine to increase stool bulk and facilitate passage. 2
Dosing Algorithm for PEG
- Initial dose: 17 g once daily, mixed in 4-8 ounces of liquid 2
- If inadequate response after 2-3 days: Increase to 17 g twice daily (34 g total daily dose) 2
- Titration: Continue adjusting dose upward based on clinical response with no clear maximum dose 1, 2
- Treatment goal: Achieve one non-forced bowel movement every 1-2 days 2
- Duration: PEG has proven durability and safety for 6 months or longer of continuous use 2
Key Clinical Considerations for PEG
- Ensure adequate hydration while on PEG therapy, particularly in patients with low baseline fluid intake 2
- Common side effects include abdominal distension, loose stools, flatulence, and nausea 2
- Monthly cost is $10-$45, making it highly cost-effective compared to prescription secretagogues 2
Alternative First-Line Osmotic Laxatives
If PEG is not tolerated or unavailable:
- Magnesium oxide 400-500 mg daily can be used, but exercise caution in renal insufficiency and pregnancy 1
- Lactulose 15 g daily is another option, though bloating and flatulence may limit tolerability 1
Second-Line Prescription Options: Stimulant Laxatives
Use stimulant laxatives only for short-term rescue therapy or when osmotic laxatives provide inadequate response. 1
- Bisacodyl 5 mg daily (maximum 10 mg daily) for short-term use 1
- Note: Bisacodyl produces the greatest increase in bowel movements (6.8 spontaneous bowel movements per week after eliminating placebo effect) but shows the most noticeable loss of efficacy between week 1 and week 4 3
- Senna 8.6-17.2 mg daily (maximum 4 tablets twice daily) as second-line treatment, though long-term safety and efficacy data are limited 1
Important Caveat on Stimulant Laxatives
Stimulant laxatives are exclusively designated for as-needed use, not chronic daily therapy. 4 Reserve these for rescue situations or when osmotic laxatives fail.
Third-Line Prescription Options: Secretagogues and Prokinetics
For refractory cases that fail PEG and stimulant laxatives, consider prescription secretagogues or prokinetic agents. 1
Secretagogues (Intestinal Fluid Secretion Enhancers)
- Lubiprostone 24 mcg twice daily increases intestinal secretion and may provide additional benefit for abdominal pain 1
- Linaclotide 72-145 mcg daily (maximum 290 mcg daily) is a guanylate cyclase-C agonist that increases intestinal secretion and may benefit abdominal pain 1, 5
- Linaclotide is appropriate as first-line prescription treatment specifically for IBS-C, but for chronic idiopathic constipation, osmotic laxatives should be tried first due to considerably lower cost 6
- Plecanatide 3 mg daily (no titration needed) is another guanylate cyclase-C agonist for refractory cases 1
- Note: Plecanatide yields the lowest increase in bowel movements among prescription agents (approximately 4 times less than bisacodyl) 3
Prokinetic Agent
- Prucalopride 1-2 mg daily (maximum 2 mg daily) is a serotonin type 4 (5-HT4) receptor agonist that enhances colonic motility and may provide additional benefit for abdominal pain 1, 5
Treatment Algorithm Summary
- Start with PEG 17 g daily as the most cost-effective option with best evidence for long-term use 1
- If inadequate response after 2-3 days: Titrate PEG dose upward 1
- If PEG alone fails: Add or switch to stimulant laxatives (bisacodyl or senna) for short-term use 1
- Before escalating to prescription secretagogues: Rule out fecal impaction and bowel obstruction 2
- For refractory cases: Consider prescription secretagogues (lubiprostone, linaclotide, plecanatide) or prokinetic agent (prucalopride) 1
- At 4 weeks: If no improvement despite maximum therapy, reassess and consider switching agents 5
Common Pitfalls to Avoid
- Do not prescribe docusate (stool softener) for established constipation—it is ineffective and not recommended 2
- Avoid supplemental fiber (psyllium) for established constipation, as it may worsen symptoms 2
- Do not use stimulant laxatives as chronic daily therapy—they are for short-term or as-needed use only 1, 4
- Ensure adequate hydration with any constipation therapy to optimize efficacy 5, 2
Supporting Dietary Measures
While not prescription medications, advise patients to maintain adequate fiber intake of 14 g per 1,000 kcal daily, as fiber supplementation can help with chronic constipation when combined with pharmacotherapy. 1